about
The role of the D(2) dopamine receptor (D(2)R) in A(2A) adenosine receptor (A(2A)R)-mediated behavioral and cellular responses as revealed by A(2A) and D(2) receptor knockout miceStriatal adenosine A2A and cannabinoid CB1 receptors form functional heteromeric complexes that mediate the motor effects of cannabinoidsDopamine D4 receptors are heterogeneously distributed in the striosomes/matrix compartments of the striatumExpression of D4 dopamine receptors in striatonigral and striatopallidal neurons in the rat striatumEmbryonic defence mechanisms against glucose-dependent oxidative stress require enhanced expression of Alx3 to prevent malformations during diabetic pregnancy.Selective vulnerability in striosomes and in the nigrostriatal dopaminergic pathway after methamphetamine administration : early loss of TH in striosomes after methamphetamine.Dopamine D1-histamine H3 receptor heteromers provide a selective link to MAPK signaling in GABAergic neurons of the direct striatal pathway.Molecular dissection of dopamine receptor signaling.Adenosine A₂A receptors in striatal glutamatergic terminals and GABAergic neurons oppositely modulate psychostimulant action and DARPP-32 phosphorylation.Striatal activation by optogenetics induces dyskinesias in the 6-hydroxydopamine rat model of Parkinson disease.Cellular responses to psychomotor stimulant and neuroleptic drugs are abnormal in mice lacking the D1 dopamine receptorL-DOPA Oppositely Regulates Synaptic Strength and Spine Morphology in D1 and D2 Striatal Projection Neurons in Dyskinesia.A spontaneous deletion of α-synuclein is associated with an increase in CB1 mRNA transcript and receptor expression in the hippocampus and amygdala: effects on alcohol consumption.New strategies in neuroprotection and neurorepair.Striatal Signaling in L-DOPA-Induced Dyskinesia: Common Mechanisms with Drug Abuse and Long Term Memory Involving D1 Dopamine Receptor Stimulation.The role of dopamine receptors in the neurotoxicity of methamphetamine.Dyskinesia in Parkinson's disease: mechanisms and current non-pharmacological interventions.Nurr1 blocks the mitogenic effect of FGF-2 and EGF, inducing olfactory bulb neural stem cells to adopt dopaminergic and dopaminergic-GABAergic neuronal phenotypes.Methamphetamine causes degeneration of dopamine cell bodies and terminals of the nigrostriatal pathway evidenced by silver staining.The T-box brain 1 (Tbr1) transcription factor inhibits astrocyte formation in the olfactory bulb and regulates neural stem cell fate.Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms.D1 but not D4 dopamine receptors are critical for MDMA-induced neurotoxicity in mice.Dopamine D(1) receptor deletion strongly reduces neurotoxic effects of methamphetamine.Persistent MDMA-induced dopaminergic neurotoxicity in the striatum and substantia nigra of mice.Fragment C Domain of Tetanus Toxin Mitigates Methamphetamine Neurotoxicity and Its Motor Consequences in Mice.Neonatal administration of vasopressin antiserum induces long-term deficits on active and passive avoidance behaviour in rats.Prolonged treatment with pramipexole promotes physical interaction of striatal dopamine D3 autoreceptors with dopamine transporters to reduce dopamine uptake.Methamphetamine and Parkinson's disease.L-DOPA treatment selectively restores spine density in dopamine receptor D2-expressing projection neurons in dyskinetic mice.Nitric oxide synthase inhibition decreases l-DOPA-induced dyskinesia and the expression of striatal molecular markers in Pitx3(-/-) aphakia mice.Genetic inactivation of pleiotrophin triggers amphetamine-induced cell loss in the substantia nigra and enhances amphetamine neurotoxicity in the striatum.Circuit-specific signaling in astrocyte-neuron networks in basal ganglia pathways.Distribution of diacylglycerol lipase alpha, an endocannabinoid synthesizing enzyme, in the rat forebrain.Nrf2 deficiency potentiates methamphetamine-induced dopaminergic axonal damage and gliosis in the striatum.Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors.Network-level changes in expression of inducible Fos-Jun proteins in the striatum during chronic cocaine treatment and withdrawal.Molecular phenotype of rat striatal neurons expressing the dopamine D5 receptor subtype.Associative learning and CA3-CA1 synaptic plasticity are impaired in D1R null, Drd1a-/- mice and in hippocampal siRNA silenced Drd1a mice.Intra-accumbens rimonabant is rewarding but induces aversion to cocaine in cocaine-treated rats, as does in vivo accumbal cannabinoid CB1 receptor silencing: critical role for glutamate receptors.Long-term hyperalgesia in rats induced by neonatal administration of vasopressin antiserum.
P50
Q28348761-85F19333-42C0-4018-82EB-372A5786DAE9Q28571785-743EFC40-82C8-4326-B2B2-72AFAA7F020CQ28576571-57C764CE-0C23-44D3-917D-45EACC76199EQ28579277-5D2AA6B9-C7D7-48AC-A0C5-3B545A58BA54Q33670696-46A806A9-F5D9-4F97-8759-447ACE7C3544Q33873281-2FF502FB-BFC3-4B37-A11D-50984F80BFF5Q34568648-2F1F6CE8-514F-4163-A700-4BCC197DFA80Q34669781-E8885CFB-9CCA-4A71-9A80-4D4959236833Q35060382-9ADC7E84-9B73-467E-BE65-64218008D1E8Q36296271-64739DC0-B5C7-4C71-BE6F-D6A42D1BBC15Q37056920-E75F4E6B-080A-42F5-B582-34E8E68EF8A3Q37344222-9D6E1239-55A3-4E96-967E-136D9523AD37Q37597181-B803C79B-97A2-4F67-8FD2-2986F04CE47EQ37921204-19AEF644-5716-4E3E-933D-148F4D8687F5Q37925513-0CCD0448-2012-4B72-9FB7-079F83FE37EAQ38100197-14BD2834-2911-4588-A289-1033118D2A1EQ38207680-D315F202-4135-4FDC-838A-E9F406E0830FQ38302745-7CA6D57A-414B-4088-BAEE-B2EC74DE5567Q38309143-86472E59-57B7-45EF-9ECA-CB054F9CD065Q38341256-1D53650E-7E18-4CD2-89D1-2DC5D9A82CBBQ38604001-C2176177-B1BF-4B2E-B528-1B32F05D1049Q40227540-5DCE5CC5-855E-4994-A76C-345387101BB3Q40304807-48A92810-1958-4F0F-A8D3-EB9F03E1BB71Q40408434-CC8DC188-0F21-42C1-9CFE-AA87D12DA631Q40983371-2BA3E182-9E10-4F47-8844-F46D4397A779Q41456656-F531A460-4F8C-411D-BB3F-3D4971D65066Q41685588-4C5C95EF-898C-4E8E-B005-D67478776429Q41860851-2C0FE5BF-B324-42B8-8EDB-7D724A8AB65BQ42440010-12249E5C-7672-401E-88EF-57FE634DCB1DQ42466609-D4E47E98-F15A-4D3F-A2FC-8928DBB01F66Q42474113-8360FFD1-AE1B-4850-B9BE-8FB5598A82E7Q42481102-72C2B687-18B6-432C-B32B-A4474ED870FDQ42491536-2CBA8CCE-E277-41D2-A42B-E0E06F9A47DEQ42493676-ECC21F52-BC06-4711-A5FC-C6F4DBFE8949Q42520647-1BB7CAAF-6C63-45BB-AFCB-19FF113EF6AAQ42521545-FE4133DF-8761-420F-BAE4-4919BC4BD7BDQ42528574-999F7CD5-865A-4634-A436-4378FCF978EEQ42906391-5FDA465B-37AE-4B5D-98D8-FE1A2A0AEB55Q43157560-06A8FDB6-A359-4F24-B28F-C25B2E43B255Q43965546-A77020BD-FCF8-4A85-8697-6E392CECCC21
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Rosario Moratalla
@ast
Rosario Moratalla
@en
Rosario Moratalla
@es
Rosario Moratalla
@nl
Rosario Moratalla
@sl
type
label
Rosario Moratalla
@ast
Rosario Moratalla
@en
Rosario Moratalla
@es
Rosario Moratalla
@nl
Rosario Moratalla
@sl
altLabel
Moratalla R
@en
prefLabel
Rosario Moratalla
@ast
Rosario Moratalla
@en
Rosario Moratalla
@es
Rosario Moratalla
@nl
Rosario Moratalla
@sl
P1053
H-9280-2015
P106
P1153
7004238296
P21
P31
P3829
P4012
P496
0000-0002-7623-8010